DPI-3290
Из Википедије, слободне енциклопедије
| (IUPAC) ime | |
|---|---|
| (+)-3-((αR)-α-((2S,5R)-4-Allyl-2,5-dimethyl-1-piperazinyl)-3-hydroxybenzyl)-N-(3-fluorophenyl)-N-methylbenzamide | |
| Klinički podaci | |
| Identifikatori | |
| ATC kod | nije dodeljen |
| PubHem | 5242141 |
| Hemijski podaci | |
| Formula | C30H34FN3O2 |
| Mol. masa | 487.607 g/mol |
| SMILES | eMolekuli & PubHem |
| Farmakoinformacioni podaci | |
| Trudnoća | ? |
| Pravni status | |
DPI-3290 je lek koji se koristi u naučnim istraživanjima. On je potentan analgetik,[1] koji zaziva neznatnu respiratornu depresiju.[2]
DPI-3290 deluje kao agonist μ- i δ-opioidnog receptora, sa IC50 vrednošću od 6.2 nM na μ i 1.0 nM na δ.[3]
Literatura [уреди]
- ^ Gengo, PJ; Pettit, HO; O'Neill, SJ; Wei, K; McNutt, R; Bishop, MJ; Chang, KJ (2003). „DPI-3290 (+)-3-((alpha-R)-alpha-((2S,5R)-4-allyl-2,5-dimethyl-1-piperazinyl)-3-hydroxybenzyl)-N-(3-fluorophenyl)-N-methylbenzamide. I. A mixed opioid agonist with potent antinociceptive activity“. The Journal of pharmacology and experimental therapeutics 307 (3): 1221–6. DOI:10.1124/jpet.103.054361. PMID 14534368.
- ^ Gengo, PJ; Pettit, HO; O'Neill, SJ; Su, YF; McNutt, R; Chang, KJ (2003). „DPI-3290 (+)-3-((alpha-R)-alpha-((2S,5R)-4-Allyl-2,5-dimethyl-1-piperazinyl)-3-hydroxybenzyl)-N-(3-fluorophenyl)-N-methylbenzamide. II. A mixed opioid agonist with potent antinociceptive activity and limited effects on respiratory function“. The Journal of pharmacology and experimental therapeutics 307 (3): 1227–33. DOI:10.1124/jpet.103.054429. PMID 14534367.
- ^ Ananthan S. Opioid ligands with mixed mi/delta opioid receptor interactions: an emerging approach to novel analgesics. AAPS Journal. 2006 Mar 10;8(1):E118-25. DOI 10.1208/aapsj080114 PMID 16584118
| Molimo Vas, obratite pažnju na važno upozorenje u vezi sa temama iz oblasti medicine (zdravlja). |